Genentech
OCREVUS
Manufacturer:
Genentech
Name:
OCREVUS
HCPCS Code Descriptor:
Injection, ocrelizumab, 1 mg
Category:
J Code
HCPCS:
J2350
NDC(s):
50242-0150-01
Primary Type:
Neurology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
OCREVUS is a Neurology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J2350 is aligned to the drug OCREVUS.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/18
HCPCS Effective Date:
1/1/18
HCPCS Short Description:
Injection, ocrelizumab, 1 mg
Billing and Coding Guide:
https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/OCREVUS-Billing-Coding-for-MS.pdf
Patient Assistance:
https://www.gene.com/patients/patient-foundation